Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Unicycive Therapeutics
UNCY
$150M
| $128K | ﹤0.01% |
9,286
+5,877
| +172% | +$71.3K |
|
3327
American Shared Hospital Services
AMS
$10.2M
| $125K | ﹤0.01% |
42,300
+6,800
| +19% | +$18.2K |
|
3328
Entera Bio
ENTX
$138M
| $125K | ﹤0.01% |
74,900
+17,500
| +30% | +$19.3K |
|
3329
SES AI
SES
$227M
| $125K | ﹤0.01% |
74,500
-12,400
| -14% | -$18.6K |
|
3330
FingerMotion
FNGR
$16.9M
| $124K | ﹤0.01% |
+59,000
| New | +$151K |
|
3331
Broadwind
BWEN
$129M
| $121K | ﹤0.01% |
50,736
-50,964
| -50% | -$125K |
|
|
EHAB
3332
DELISTED
Enhabit
EHAB
| $121K | ﹤0.01% |
+10,400
| New | +$104K |
|
|
TIGR
3333
UP Fintech Holding
TIGR
$833M
| $121K | ﹤0.01% |
35,184
-180,000
| -84% | -$713K |
|
3334
American Express Global Business Travel
GBTG
$4.93B
| $120K | ﹤0.01% |
19,900
-2,500
| -11% | -$14.6K |
|
|
SEI
3335
Solaris Energy Infrastructure
SEI
$4.07B
| $120K | ﹤0.01% |
13,800
-228,900
| -94% | -$1.8M |
|
|
TWKS
3336
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $120K | ﹤0.01% |
47,300
-166,197
| -78% | -$637K |
|
|
NBP
3337
NovaBridge Biosciences American Depositary Shares
NBP
$216M
| $119K | ﹤0.01% |
63,800
| – | – |
|
|
STRR
3338
DELISTED
Star Equity Holdings
STRR
| $118K | ﹤0.01% |
26,620
-4,020
| -13% | -$19.1K |
|
3339
Drilling Tools International
DTI
$86.1M
| $117K | ﹤0.01% |
39,000
-4,300
| -10% | -$12.8K |
|
|
AINC
3340
DELISTED
Ashford Inc.
AINC
| $117K | ﹤0.01% |
51,553
-600
| -1% | -$1.66K |
|
3341
KORU Medical Systems
KRMD
$154M
| $116K | ﹤0.01% |
+49,300
| New | +$106K |
|
|
ORKA
3342
Oruka Therapeutics
ORKA
$7.11B
| $116K | ﹤0.01% |
5,475
+700
| +15% | +$13.9K |
|
|
VWE
3343
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
| $116K | ﹤0.01% |
321,700
-47,700
| -13% | -$21.7K |
|
|
EGIO
3344
DELISTED
Edgio, Inc. Common Stock
EGIO
| $115K | ﹤0.01% |
11,957
+3,492
| +41% | +$33.5K |
|
|
VSTA
3345
DELISTED
Vasta Platform
VSTA
| $114K | ﹤0.01% |
28,300
+6,300
| +29% | +$25.4K |
|
3346
SOPHiA GENETICS
SOPH
$644M
| $113K | ﹤0.01% |
22,900
+1,600
| +8% | +$7.73K |
|
3347
Elutia
ELUT
$38M
| $112K | ﹤0.01% |
35,616
-5,561
| -14% | -$19.3K |
|
3348
Matinas BioPharma
MTNB
$1.49M
| $112K | ﹤0.01% |
8,281
+848
| +11% | +$10.1K |
|
3349
Mexco Energy
MXC
$20M
| $112K | ﹤0.01% |
11,200
-1,300
| -10% | -$13K |
|
|
TMQ
3350
Trilogy Metals
TMQ
$650M
| $112K | ﹤0.01% |
223,300
-285,226
| -56% | -$133K |
|
Similar funds
Jim Simons's Q1 2024 Portfolio in Review
As of Q1 2024, Jim Simons held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Chevron worth $331M.
- Jim Simons's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Jim Simons added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Jim Simons's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Jim Simons fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Jim Simons's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Jim Simons opened 562 new positions and closed 582 in Q1 2024.
- Jim Simons's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.